title: A practical guide to community-acquired MRSA.
abstract: As the number of CA-MRSA skin and soft tissue infections continues to grow, it's important to know which patients are at greatest risk and which evidence-based treatment protocols to turn to when needed.
authors.affiliation: Department of Family Medicine, Mayo Clinic, Jacksonville, FL, USA. Email: presutti.richard@mayo.edu.
authors.forename: Aristides
authors.initials: A
authors.lastname: Sastre
authors.forename: Paul F
authors.initials: PF
authors.lastname: Roberts
authors.forename: R John
authors.initials: RJ
authors.lastname: Presutti
mesh_terms: D000081:Acetamides / Q000191:economics / Q000627:therapeutic use; D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D002981:Clindamycin / Q000191:economics / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy; D003266:Continuity of Patient Care; D003428:Cross Infection / Q000175:diagnosis; D005006:Ethnicity; D006801:Humans; D000069349:Linezolid; D008487:Medical History Taking; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D016712:Mupirocin / Q000008:administration & dosage; D023303:Oxazolidinones / Q000191:economics / Q000627:therapeutic use; D010353:Patient Education as Topic; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D055502:Secondary Prevention; D012867:Skin / Q000293:injuries; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000635:transmission; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000191:economics / Q000627:therapeutic use
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D002981:Clindamycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D016712:Mupirocin; D000069349:Linezolid; D012293:Rifampin